AMPHQT73Amphastar Pharmaceuticals, Inc.·NASDAQ
27.03-2.49%

Latest SEC Filings

Form category
DescriptionFilingDocument
Sep 23, 20264Statement of changes in beneficial ownership
Sep 17, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 11, 20264Statement of changes in beneficial ownership
Aug 06, 202610-QQuarterly report
Aug 06, 20268-KCurrent report
Jul 14, 2026SC 13GBeneficial ownership statement (passive)
Jul 13, 20263Initial statement of beneficial ownership
Jul 13, 20264Statement of changes in beneficial ownership
Jul 13, 20268-KCurrent report
Jul 08, 20268-KCurrent report
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
Jun 03, 20264Statement of changes in beneficial ownership
May 07, 202610-QQuarterly report
May 07, 20268-KCurrent report
Apr 13, 2026DEF 14ADefinitive proxy statement
Apr 13, 2026ARSAnnual report to shareholders
Apr 13, 2026DEFA14AAdditional proxy soliciting materials
Mar 26, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Mar 17, 20264Statement of changes in beneficial ownership